Bristol-Myers Squibb Co (BMY)
44.72
-0.34
(-0.77%)
USD |
NYSE |
May 14, 16:00
44.75
+0.04
(+0.08%)
After-Hours: 20:00
Bristol-Myers Squibb Profit Margin (Quarterly): -100.4% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -100.4% |
December 31, 2023 | 15.35% |
September 30, 2023 | 17.58% |
June 30, 2023 | 18.47% |
March 31, 2023 | 19.95% |
December 31, 2022 | 17.73% |
September 30, 2022 | 14.32% |
June 30, 2022 | 11.95% |
March 31, 2022 | 10.97% |
December 31, 2021 | 19.79% |
September 30, 2021 | 13.30% |
June 30, 2021 | 9.01% |
March 31, 2021 | 18.25% |
December 31, 2020 | -90.59% |
September 30, 2020 | 17.76% |
June 30, 2020 | -0.84% |
March 31, 2020 | -7.19% |
December 31, 2019 | -13.29% |
September 30, 2019 | 22.52% |
June 30, 2019 | 22.83% |
March 31, 2019 | 28.89% |
December 31, 2018 | 19.42% |
September 30, 2018 | 33.40% |
June 30, 2018 | 6.54% |
March 31, 2018 | 28.62% |
Date | Value |
---|---|
December 31, 2017 | -42.72% |
September 30, 2017 | 16.08% |
June 30, 2017 | 17.81% |
March 31, 2017 | 31.93% |
December 31, 2016 | 17.05% |
September 30, 2016 | 24.42% |
June 30, 2016 | 23.94% |
March 31, 2016 | 27.21% |
December 31, 2015 | -4.60% |
September 30, 2015 | 17.35% |
June 30, 2015 | -3.12% |
March 31, 2015 | 29.35% |
December 31, 2014 | 0.31% |
September 30, 2014 | 18.39% |
June 30, 2014 | 8.56% |
March 31, 2014 | 24.59% |
December 31, 2013 | 16.35% |
September 30, 2013 | 17.02% |
June 30, 2013 | 13.24% |
March 31, 2013 | 15.90% |
December 31, 2012 | 22.07% |
September 30, 2012 | -19.03% |
June 30, 2012 | 14.52% |
March 31, 2012 | 20.97% |
December 31, 2011 | 15.62% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-100.4%
Minimum
Mar 2024
22.83%
Maximum
Jun 2019
1.87%
Average
14.83%
Median
Profit Margin (Quarterly) Benchmarks
Amgen Inc | -1.52% |
Gilead Sciences Inc | -62.37% |
Johnson & Johnson | 15.22% |
Eli Lilly and Co | 25.58% |
2seventy bio Inc | -423.6% |
Profit Margin (Quarterly) Related Metrics
Return on Equity | -22.11% |
Return on Assets | -6.50% |
Return on Invested Capital | -8.84% |
Gross Profit Margin (Quarterly) | 75.29% |
Operating Margin (Quarterly) | 12.76% |
Return on Net Operating Assets | -7.92% |